EMBC
Medical Instruments & Supplies · Healthcare
CFO
Head of Investor Relations
Teleflex Inc (TFX)Equibles does not estimate personal net worth.
Get an email with a short summary when Embecta Corp. publishes a filing, an earnings call transcript or a press release.
Get EMBC alertsJake Elguicze is recorded as CFO at Embecta Corp. (EMBC) and Head of Investor Relations at Teleflex Inc (TFX). The proxy statement of Embecta Corp. reports total compensation of $3,459,049 for Jake Elguicze in fiscal 2025, including a base salary of $603,077. Disclosed compensation is on record for 5 fiscal years. Jake Elguicze has spoken on 17 earnings calls across 2 companies, most recently for Embecta Corp. on May 5, 2026. Those appearances were for Embecta Corp. (EMBC) and Teleflex Inc (TFX). Embecta Corp. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Teleflex Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Embecta Corp. includes David F. Melcher (Chairman), Devdatt (Dev) Kurdikar (Chairman), Jacob Elguicze (CFO) and 7 others.
“Since Dev outlined the items impacting Q2 revenue I will keep my comments brief. During the second quarter, Invecta generated approximately $222 million in revenue, which is a year-over-year decline of 14.4% on an as-reported basis, or 17.4% on an adjusted constant currency basis.”
“Given the discussion that has already occurred regarding revenue, I will start my review of Mbecta's first quarter financial performance at the gross profit line.”
“Given the discussion that has already occurred regarding revenue, I will start my review of Imbecta's fourth quarter financial performance at the gross profit line.”
“Given the discussion that has already occurred regarding revenue, I will start my review of Embecta’s second quarter financial performance at the gross profit line.”
“Given the discussion that has already occurred regarding revenue, I will start my review of Embecta Corp.'s first quarter financial performance at the gross profit line.”
EMBC
Medical Instruments & Supplies · Healthcare
CFO
TFX
Medical Instruments & Supplies · Healthcare
Head of Investor Relations
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Embecta Corp. (EMBC) | Senior Vice President and Chief Financial Officer | $603,077 | $3,459,049 |
| 2024 | Embecta Corp. (EMBC) | Senior Vice President and Chief Financial Officer | $557,227 | $3,116,275 |
| 2023 | Embecta Corp. (EMBC) | Senior Vice President and Chief Financial Officer | $528,846 | $2,583,449 |
| 2022 | Embecta Corp. (EMBC) | Senior Vice President and Chief Financial Officer | $485,493 | $3,642,020 |
| 2021 | Embecta Corp. (EMBC) | Senior Vice President and Chief Financial Officer | $182,466 | $716,439 |